Cytophage Technologies Ltd

NEW
TSXV:CYTO.H (Canada)  
C$ 0.0050 (0%) Jul 3
At Loss
P/B:
0.22
Market Cap:
C$ 338.00K ($ 238.00K)
Enterprise V:
C$ 1.16M ($ 818.00K)
Volume:
0
Avg Vol (2M):
581.82K
Trade In:
Volume:
0
At Loss
Avg Vol (2M):
581.82K

Business Description

Description
Cytophage Technologies Ltd is a Canadian biotechnology company engaged in the development of bacteriophages using molecular genetics and synthetic biology techniques. The company focuses on developing bacteriophage-based solutions to address bacterial challenges affecting animal health, human health, and food security, including antibiotic-resistant bacterial strains.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt
0.38
Equity-to-Asset
0.48
Debt-to-Equity
0.83
Debt-to-EBITDA
-0.39
Piotroski F-Score
2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
13.51
9-Day RSI
25.3
14-Day RSI
30.87
3-1 Month Momentum %
-90.91
6-1 Month Momentum %
-96.43
12-1 Month Momentum %
-97.22

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
1.33
Quick Ratio
1.33
Cash Ratio
0.75

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-8
Shareholder Yield %
-750.8

Profitability Rank

Name Current Vs Industry Vs History
ROE %
-215.4
ROA %
-106.81
ROIC %
-136.03
3-Year ROIIC %
-235.92
ROC (Joel Greenblatt) %
-147.25
ROCE %
-129.4

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio
0.22
Price-to-Tangible-Book
0.25
EV-to-EBIT
-0.29
EV-to-EBITDA
-0.35
EV-to-FCF
-0.34
Earnings Yield (Greenblatt) %
-344.83
FCF Yield %
-1017.46
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Cytophage Technologies Ltd Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$)
EPS (TTM) (C$) -0.07
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % 111.1
14-Day RSI 30.87
14-Day ATR (C$) 0.00088
20-Day SMA (C$) 0.005
12-1 Month Momentum % -97.22
52-Week Range (C$) 0.005 - 0.32
Shares Outstanding (Mil) 67.69

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cytophage Technologies Ltd Filings

Filing Date Document Date Form
No Filing Data

Cytophage Technologies Ltd Stock Events

Financials Calendars
Event Date Price (C$)
No Event Data

Cytophage Technologies Ltd Frequently Asked Questions

What is Cytophage Technologies Ltd(TSXV:CYTO.H)'s stock price today?
The current price of TSXV:CYTO.H is C$0.01. The 52 week high of TSXV:CYTO.H is C$0.32 and 52 week low is C$0.01.
When is next earnings date of Cytophage Technologies Ltd(TSXV:CYTO.H)?
The next earnings date of Cytophage Technologies Ltd(TSXV:CYTO.H) is .
Does Cytophage Technologies Ltd(TSXV:CYTO.H) pay dividends? If so, how much?
Cytophage Technologies Ltd(TSXV:CYTO.H) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Cytophage Technologies Ltd

No articles.